Charissa Elizabeth Carroll, APRN

Charissa Carroll practices at Rizzi Psychiatric Associates Inc in Estero, Florida.

Charissa Carroll's NPI, 1699381483, was assigned on September 17, 2020. Charissa Carroll holds Florida license APRN11013240.

Charissa Carroll's primary practice is Rizzi Psychiatric Associates Inc, at 8460 Murano Del Lago Dr, Estero, FL 34135 in Lee County. The practice phone is (239) 265-3391.

Charissa Carroll's primary practice is Rizzi Psychiatric Associates Inc in Estero, Florida. The medical group on file is Legacy Healthcare Services. Dmand AI also links Charissa Carroll to 4 more group practices and clinics, 4 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Charissa Carroll practices, 5 sites in all. Vendor and product names are available with a free account.

Family is Charissa Carroll's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Charissa Carroll is licensed in Florida.

Dmand AI lists alzheimer's disease, anxiety, bipolar disorder, depression, epilepsy, insomnia, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Charissa Carroll treats.

CMS data shows 2,928 Medicare services from Charissa Carroll across 4 procedure codes in 2024, for 205 Medicare patients. Medicare paid $356,117 for them. Every service was in an office.

CMS counts 205 Medicare patients who saw Charissa Carroll in 2024. The largest group is 85 and over, with 116 patients. 75% of them have alzheimer's and dementia, and 75% have anxiety. 9% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Charissa Carroll's median patient age at 85, with 61% women.

In 2024, Charissa Carroll wrote 851 Medicare Part D claims for 119 patients. 95% of them were for generic drugs. CMS names the drug for 696 of them, across 18 drugs with 11 or more claims each, at $12,455 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 39 out of 100 for Charissa Carroll for performance year 2024, reported as part of a group. Charissa Carroll accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Charissa Carroll from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $18.